NCOA7 promotes OSCC progression by inhibiting ROS-regulated ferroptosis
NCOA7 promotes OSCC progression by inhibiting ferroptosis through ROS signaling. NCOA7 might be a new therapeutic target for OSCC.
Authors
- Hang Si
- Xinyue Liao (ORCID: https://orcid.org/0000-0001-5302-8793)
- Tailai Zhou
- Xiaoyan Zhang (ORCID: https://orcid.org/0000-0002-1344-6728)
- Li Yu (ORCID: https://orcid.org/0000-0002-8205-7777)
- Yan Feng (ORCID: https://orcid.org/0000-0001-8610-1619)
- Yun Feng
- Yongxian Lai
Institutions
- Southwest Medical University (CN)
- Affiliated Hospital of Southwest Medical University (CN)
- Mianyang Central Hospital (CN)
Publication Details
- Journal
- Cellular and Molecular Life Sciences
- Published
- 2026-01-06
- DOI
- https://doi.org/10.1007/s00018-025-06018-8
- Primary Topic
- Ferroptosis and cancer prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00